Ms Stephanie Green, MS, OTR/L | |
40 Taft St, Westminster, VT 05158-9708 | |
(802) 376-9721 | |
Not Available |
Full Name | Ms Stephanie Green |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 40 Taft St, Westminster, Vermont |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1902511744 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | (Vermont) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ms Stephanie Green, MS, OTR/L 40 Taft St, Westminster, VT 05158-9708 Ph: () - | Ms Stephanie Green, MS, OTR/L 40 Taft St, Westminster, VT 05158-9708 Ph: (802) 376-9721 |
News Archive
Autism Speaks, the world's leading autism science and advocacy organization, today called on the nation's elected and appointed leaders to immediately develop a new, coordinated strategy to take on a national public health emergency - the autism epidemic - in the wake of a new report from the U.S. Centers for Disease Control (CDC) finding that autism is now diagnosed in a staggering 1 in every 88 American children.
UCLA life scientists and their colleagues have provided the first evidence of a causal link between traumatic brain injury and an increased susceptibility to post-traumatic stress disorder.
In a study conducted at the Mayo Clinic, USA, scientists have investigated the long-term efficacy of the mRNA-based coronavirus disease 2019 (COVID-19) vaccine BNT162b2 (Pfizer/BioNTech) against symptomatic disease.
Today, Virgin HealthMiles, a provider of incentives-based health and productivity programs for business and government, lent its support to the newly-launched Healthy Weight Commitment Foundation, which aims to help reduce U.S. obesity rates by increasing access and opportunities for physical activity, healthier nutrition options and raising awareness of the energy balance approach - in the marketplace, in the workplace and in schools.
Tranzyme Pharma announced today that data from the Phase 2 clinical trial of ulimorelin (TZP-101) for the treatment of severe gastroparesis have been selected for an oral presentation at Digestive Disease Week (DDW) 2010 being held May 1-5, 2010 in New Orleans, LA.
› Verified 3 days ago
Ms. Elizabeth Blum, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4923 Us Route 5, Sojourns Community Health Clinic, Westminster, VT 05158 Phone: 802-722-4023 Fax: 802-722-4137 | |
Ms. Martha Hennessy, OTR L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4923 Us Rt Five, Westminster, VT 05158 Phone: 802-722-4023 Fax: 802-722-4137 | |
Shelley L Earley, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 4923 Us Route 5, Sojourns Community Health Clinic, Westminster, VT 05158 Phone: 802-722-4023 Fax: 802-722-4137 |